Intuitive Surgical, Inc. $ISRG Shares Sold by Catalina Capital Group LLC

Catalina Capital Group LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,809 shares of the medical equipment provider’s stock after selling 146 shares during the quarter. Catalina Capital Group LLC’s holdings in Intuitive Surgical were worth $983,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Norway Savings Bank boosted its position in shares of Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after purchasing an additional 910 shares in the last quarter. IronOak Wealth LLC. acquired a new stake in Intuitive Surgical during the 2nd quarter worth about $1,099,000. Trust Co. of Oklahoma acquired a new stake in Intuitive Surgical during the 2nd quarter worth about $363,000. Neville Rodie & Shaw Inc. lifted its position in Intuitive Surgical by 11.9% during the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after acquiring an additional 1,110 shares during the period. Finally, Banque Pictet & Cie SA lifted its position in Intuitive Surgical by 12.1% during the 2nd quarter. Banque Pictet & Cie SA now owns 37,768 shares of the medical equipment provider’s stock worth $20,524,000 after acquiring an additional 4,085 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $443.01 on Friday. The stock has a 50-day simple moving average of $464.42 and a two-hundred day simple moving average of $500.22. The firm has a market capitalization of $158.81 billion, a P/E ratio of 61.79, a PEG ratio of 4.59 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter last year, the business posted $1.78 EPS. The company’s revenue was up 21.4% on a year-over-year basis. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on ISRG shares. Truist Financial lifted their price target on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. BTIG Research reaffirmed a “buy” rating and set a $571.00 price target on shares of Intuitive Surgical in a research report on Wednesday. Finally, Evercore ISI lifted their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. Fourteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $594.19.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.